B+
Bull case
20%
Probability
Target price
$36.00
Analysis reference price unavailable
Analysis 2026-08-08 · RankAlpha Sentiment Codex
HSTM
HealthStreamBNasdaq / Health Care Equipment & Services
Last Price
Quote time unavailable
AI scenario view
RankAlpha Sentiment CodexMost likely
B
Base case
50%
Probability
Target price
$30.00
Analysis reference price unavailable
Analysis 2026-08-08 · RankAlpha Sentiment Codex
B-
Bear case
30%
Probability
Target price
$23.50
Analysis reference price unavailable
Analysis 2026-08-08 · RankAlpha Sentiment Codex
The current persistence contract does not provide an exact AI reference price. RankAlpha therefore does not calculate scenario return from the live quote. How scenarios are presented
AI sentiment snapshot
Latest data as of 2026-08-08
Recent news sentiment (30D)
+0.6
Mixed
Company
-
Unavailable
Macro
-
Unavailable
Pulse
-
Unavailable
Weekly research (10D)
+30.0
Positive
Sentiment proxy
+66.0
Score
AI commentary
Headline tone is mildly constructive after record Q2 revenue and the guidance update, but coverage is low. The packet does not provide reliable post-print market-reaction attribution, analyst estimate revisions, options data, short interest, employee sentiment, or sufficient social coverage; unavailable fields should not be interpreted as neutral or positive evidence.
RankAlpha Sentiment Codex - 2026-08-08
Open full AI memoEvidence flagged
No evidence quality warning is currently attached to this memo.
Impact
standard
Confidence
-
AI events
2026-08-03eventQ2 results and guidance updateMedium impact
Q2 revenue reached a record $83.7 million, up 12.5%, while adjusted EBITDA rose 16.9% to $20.6 million. FY2026 revenue and adjusted EBITDA guidance increased, but net income guidance was reduced; revenue growth also included $3.1 million from acquisitions and a $2.0 million variable-consideration catch-up. [#SEC-8K-2026-08-03]
2026-12-31catalystRecurring subscription and platform executionHigh impact
Subscription revenue increased 11.2% year over year, and management cited continued investment in the hStream platform and products as a driver of durable growth. Execution remains to be validated against higher personnel, cloud, commission, royalty, and amortization costs. [#SEC-8K-2026-08-03]
Recommendation
N/A
No formal recommendation provided.
As of 2026-08-08 • Updated nightlySource: Internal modelMethodology